Loading resource…
University of Michigan, University of Washington, Medical University of South Carolina, Duke University, Mount Sinai School of Medicine, University of Texas Southwestern, Einstein Healthcare Network
The document was developed by an expert panel under the American Association for the Study of Liver Diseases (AASLD) to address the needs of patients with DILI. It includes guidance statements based on a formal review of the literature and aims to assist practitioners in managing patients with DILI through risk stratification and recommendations for patient management. The guidance also discusses the classification of DILI and highlights the differences in drug-induced liver injury across various populations.
No account needed